Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

PHASE4CompletedINTERVENTIONAL
Enrollment

27,231

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
TyphoidParatyphoid Fever
Interventions
BIOLOGICAL

Typhoid Vi vaccine

Single 0.5ml dose containing 25ug purified Vi polysaccharide of S. typhi.

BIOLOGICAL

Hepatitis A vaccine

single 0.5ml dose contains 720 EL.U. of inactivated hepatitis A viral antigen

Trial Locations (1)

Unknown

Aga Khan University, Karachi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aga Khan University

OTHER

collaborator

Wellcome Trust

OTHER

collaborator

University of Western Ontario, Canada

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

International Vaccine Institute

OTHER